Cannabis Market Entry in Europe

Who this is for

This process is built for cannabis, hemp and cannabinoid companies entering Europe for the first time, expanding into another European country, choosing between markets or testing whether a product and business model can support the cost of entry.

1. Market selection

Score candidate markets on commercial merit rather than headlines: is there a legal route for your product, a channel that will carry it, a customer with budget, and a landed cost that leaves margin. Market intelligence and risk assessment should test those assumptions before capital is committed. Population size is the weakest signal.

Our cannabis market entry calculator applies a weighted version of this logic if you want a first pass in a few minutes.

2. Regulatory assessment

Classification comes before everything else. Depending on the product, cannabinoid profile, formulation and intended use, the same item can be treated as a food, a novel food, a cosmetic, a medicinal product or a controlled substance — and the answer can differ between countries.

This is commercial regulatory strategy, not legal advice. Where a formal opinion is needed, we work alongside local counsel.

3. Business model evaluation

Decide what you actually are in this market: supplier, manufacturer, brand owner, licensor or partner. Foreign companies frequently default to 'brand' because that is what they are at home, then discover the channel is closed to them.

4. Product compliance

Formulation, THC content, labelling, permitted claims and packaging all need to match the applicable national framework. Adaptation cost is usually smaller than the cost of a stopped shipment or a delisting.

5. Market positioning

Positioning in a regulated category must survive both the buyer and the compliance reviewer. If the proposition only works with claims you cannot make, it is not a proposition.

6. Distribution strategy

Choose the channel deliberately: pharmaceutical wholesale, specialist retail, drugstore or grocery, cosmetics distribution, e-commerce or B2B ingredient supply. Each has different listing requirements, margin expectations and payment realities.

7. Local partnerships

In most European markets your partner is your access. Partner identification should start with channel fit, followed by diligence on licences, financial stability, existing listings and conflicting mandates. That work is worth more than a favourable first offer.

8. Launch strategy

Enter narrow: one country, one or two formats, one channel, a defined test period and a defined kill criterion. Broad launches hide which variable failed.

9. Scaling

Scale by repeating what has been proven, not by adding markets simultaneously. The second market should reuse the first market's dossier, packaging system and supply chain wherever regulation allows.

Common and expensive mistakes

The recurring pattern is spending on brand and inventory before resolving classification and channel access.

• Treating the EU as one approval area
• Choosing a market on population rather than route to revenue
• Signing an exclusive distributor before testing demand
• Copying North American claims and packaging
• Ignoring banking and payment processing until launch week